Indica Labs Release HALO™ – Next Generation Image Analysis
Indica Labs, inc. announce the availability of HALO, a next generation image analysis platform for digital pathology.
New Mexico (I-Newswire) September 29, 2012 - Indica Labs, Inc. proudly announces the availability of HALO™, the next generation image analysis platform for digital pathology. HALO is designed to be the fastest, most scalable, user-friendly image analysis software the industry has witnessed. The platform seamlessly hosts Indica’s large portfolio of morphometric and colorimetric analysis tools for neuroscience, metabolism, oncology, and toxicological pathology.
Following a successful beta program at the Novartis Institutes for BioMedical Research in Cambridge, Massachusetts, HALO is now available globally either via direct sales channels or indirectly through select distributors. The software can be licensed under both CapEx and OpEx pricing models, including pricing options for multi-seat, site-wide, and academic licenses. For additional pricing information, visit http://indicalab.com/product-halo.html.
HALO excels in providing cell-by-cell results and features an unprecedented level of interactivity between cell data and cell imagery, making it ideally suited for quantification of cell-based immunohistochemistry (IHC) and In Situ Hybridization (ISH) assays. Cell-by-cell analysis can be performed across large studies involving thousands of whole slide images, or on individual photomicrographs captured on a traditional microscope. HALO’s modular design supports both affordable, small-scale, desktop environments and high-throughput, multi-node, networked environments.
Despite HALO’s unmatched functionality and power, the platform features a remarkably simple user interface that allows researchers to quickly become comfortable and produce results within minutes. Indica CEO, Steven Hashagen, remarked “HALO’s powerful feature- set and intuitive design have been a long time in the making. We’ve spent the past year-and-a-half working with thought leaders in the industry to conceptualize what a next generation image analysis workstation would look like and now we’re seeing those concepts to fruition.”
For more information or to watch a HALO demonstration video, visit http://indicalab.com/product-halo.html or contact firstname.lastname@example.org. Indica Labs will also be exhibiting at Pathology Visions, 2012 where you can experience HALO in booth #21.
About Indica Labs
Indica Labs provides software for quantitative evaluation of pathology images. Indica’s HALO™ More..image analysis platform provides a unique combination of precision, performance, scalability, and usability. Indica’s broad range of industry leading tissue-specific image analysis algorithms can be used in a variety of truly integrated digital pathology environments, allowing pharmaceutical, healthcare, and research organizations worldwide to apply high-throughput image quantification in areas such as neuroscience, metabolism, oncology, toxicological pathology, and more. For more information, please visit http://indicalab.comLess..
274 Calle Conejo
Phone : 505 573-5167
Tags:obesity Diabetes pathology Digital Pathology Pancreas tox pathology toxicologic pathology Islet Matabolic IHC Nucleus Cytoplasm image anal
Published in:Science and Research
Published On:September 29, 2012
Print Release:Print Release
If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the I-Newswire.com press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.